PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Bio-Rad Laboratories, Inc. (BIO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US0905722072

CUSIP

090572207

Sector

Healthcare

IPO Date

Jan 1, 1966

Highlights

Market Cap

$9.55B

EPS (TTM)

-$28.07

PEG Ratio

1.19

Total Revenue (TTM)

$1.90B

Gross Profit (TTM)

$1.04B

EBITDA (TTM)

-$1.25B

Year Range

$262.12 - $387.99

Target Price

$404.33

Short %

3.18%

Short Ratio

2.94

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
BIO vs. TMO BIO vs. SPY BIO vs. VOO
Popular comparisons:
BIO vs. TMO BIO vs. SPY BIO vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Bio-Rad Laboratories, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
16.41%
3.64%
BIO (Bio-Rad Laboratories, Inc.)
Benchmark (^GSPC)

Returns By Period

Bio-Rad Laboratories, Inc. had a return of 7.06% year-to-date (YTD) and 10.40% in the last 12 months. Over the past 10 years, Bio-Rad Laboratories, Inc. had an annualized return of 11.63%, while the S&P 500 benchmark had an annualized return of 11.23%, indicating that Bio-Rad Laboratories, Inc. performed slightly bigger than the benchmark.


BIO

YTD

7.06%

1M

4.59%

6M

16.41%

1Y

10.40%

5Y*

-1.36%

10Y*

11.63%

^GSPC (Benchmark)

YTD

-0.77%

1M

-3.55%

6M

3.64%

1Y

22.00%

5Y*

12.20%

10Y*

11.23%

*Annualized

Monthly Returns

The table below presents the monthly returns of BIO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-0.62%1.56%6.13%-22.01%6.34%-4.79%23.89%-0.31%-0.81%7.06%-4.93%-3.53%1.74%
202311.17%2.22%0.25%-5.89%-17.18%1.55%6.92%-1.27%-10.43%-23.20%10.77%5.89%-23.21%
2022-20.63%4.37%-10.02%-9.09%5.02%-7.96%13.79%-13.89%-14.00%-15.69%17.91%1.39%-44.35%
2021-1.57%1.87%-2.28%10.32%-4.41%6.96%14.78%8.83%-7.31%6.53%-5.22%0.31%29.61%
2020-2.46%-2.47%-0.41%25.54%11.64%-8.11%16.26%-3.11%1.35%13.77%-8.17%8.25%57.54%
20197.60%8.42%12.84%-1.55%-4.65%8.94%0.74%7.24%-1.47%-0.34%11.39%0.18%59.34%
20188.32%4.45%-7.39%1.45%13.17%0.49%6.28%6.08%-3.78%-12.82%0.59%-15.39%-2.70%
20174.28%2.40%2.41%9.49%2.39%1.27%4.12%-7.56%2.02%-1.09%23.44%-12.03%30.94%
2016-7.97%5.51%1.54%3.75%4.93%-3.92%1.45%2.56%10.08%-3.50%9.75%5.06%31.46%
2015-5.05%11.10%6.29%-0.54%7.38%4.32%0.09%-7.57%-3.60%3.85%0.17%-0.76%15.01%
20142.84%2.05%-1.23%-3.83%-2.01%-0.84%-3.94%4.58%-5.70%-0.51%5.29%1.49%-2.47%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BIO is 57, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BIO is 5757
Overall Rank
The Sharpe Ratio Rank of BIO is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of BIO is 5454
Sortino Ratio Rank
The Omega Ratio Rank of BIO is 5353
Omega Ratio Rank
The Calmar Ratio Rank of BIO is 5656
Calmar Ratio Rank
The Martin Ratio Rank of BIO is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for BIO, currently valued at 0.29, compared to the broader market-2.000.002.000.291.73
The chart of Sortino ratio for BIO, currently valued at 0.65, compared to the broader market-4.00-2.000.002.004.000.652.33
The chart of Omega ratio for BIO, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.32
The chart of Calmar ratio for BIO, currently valued at 0.14, compared to the broader market0.002.004.006.000.142.59
The chart of Martin ratio for BIO, currently valued at 0.83, compared to the broader market0.0010.0020.000.8310.80
BIO
^GSPC

The current Bio-Rad Laboratories, Inc. Sharpe ratio is 0.29. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Bio-Rad Laboratories, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.29
1.73
BIO (Bio-Rad Laboratories, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Bio-Rad Laboratories, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-57.41%
-4.17%
BIO (Bio-Rad Laboratories, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Bio-Rad Laboratories, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bio-Rad Laboratories, Inc. was 76.26%, occurring on Aug 19, 1982. Recovery took 717 trading sessions.

The current Bio-Rad Laboratories, Inc. drawdown is 57.41%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-76.26%Jan 26, 1981397Aug 19, 1982717Jun 19, 19851114
-68.75%Feb 17, 19871740Dec 31, 1993343May 11, 19952083
-68.03%Sep 3, 2021709Jul 1, 2024
-50.88%Aug 12, 2008144Mar 9, 2009277Apr 14, 2010421
-48.46%Jul 5, 1996666Feb 24, 1999484Jan 24, 20011150

Volatility

Volatility Chart

The current Bio-Rad Laboratories, Inc. volatility is 7.53%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
7.53%
4.67%
BIO (Bio-Rad Laboratories, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bio-Rad Laboratories, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Bio-Rad Laboratories, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab